- Hematologists
- Oncologists
- Hematopathologists
Participants who engage in this educational intervention will be able to:
Hematologists/Oncologists:
- Identify appropriate ordering of expensive, ancillary diagnostic testing
- Describe the salient morphologic, immunophenotypic, cytogenetic and molecular features of common hematologic malignancies
Hematopathologists:
- Discuss emergent therapeutic options and availability of clinical trials, and how they apply to patients diagnosed in our service
- Utilize and constantly update themselves with the clinical practices of the Department of Hematology and Oncology, in order to continue to improve outcomes and provide optimal patient care
Professor of Pathology
Director of Hematopathology
Department of Pathology
Faculty Pillar Director, Robert D. and Patricia E. Kern Institute for the Transformation of Medical Education
Professor of Pathology
Director of Hematopathology
Department of Pathology
Faculty Pillar Director, Robert D. and Patricia E. Kern Institute for the Transformation of Medical Education
- Karen-Sue B. Carlson, MD, PhD
- Alexandra Harrington, MD, MT(ASCP)CM
- Lyndsey Runaas,MD
- Kelly Simarski
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
- 0.00 MOC Part IIMOC Part II credit.